Navigation Links
CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
Date:6/23/2008

f infectious disease, radiation protection, cancer, and addiction. With innovative science, proven research and development leadership, and superior products and compounds, Canopus BioPharma has, since 2001, been committed to becoming a market trend setter in a new era of healthcare. In addition, the Company is a world leader in the development of novel camelid antibody products to provide unique avenues of progress and improvement in assay methods and monitoring capabilities for physicians, patients and researchers, particularly for food chain protection applications. Canopus maintains staff in Australia, South Africa, Ireland, Panama and the USA. Additional information on the Company is available at http://www.canopusbiopharma.com.


'/>"/>
SOURCE Canopus BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
2. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
3. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
4. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
5. Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
6. Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
7. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
8. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
11. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and CEO of Regulus, will ... Annual Piper Jaffray Healthcare Conference at the New York ... p.m. EST.  The presentation will be webcast at the ...
(Date:11/26/2014)... 2014 Scott Steiger lives in ... As an engineer for the past 20 years, he,s traveled extensively ... service. He,s been to six of the seven continents. Travel is ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... a pretty good idea of what,s required. His latest ...
(Date:11/26/2014)... a leader in the development of Chimeric Antigen Receptors ... cancers, today announced the completion of a series A ... -based healthcare private equity fund.   CARsgen ... new therapeutics for liver, lung, stomach and brain cancers. ... Hospital, the company plans to initiate clinical studies for ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2CARsgen Completes Series A Financing 2
(Date:11/27/2014)... and Caicos Islands; BWI (PRWEB) November 28, 2014 ... the Tuscany Resort in the Turks & Caicos. ... by TripAdvisor in Providenciales, is announcing a few highly ... bedroom villa rentals. And they are offering every ... , Additionally, The Tuscany, is having a January ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Luciana Lagana ... to be part of Omadox, a feature film that received ... an award for best ensemble cast. It is also an ... a great start to a successful cinematic career for James ... white movies. If you enjoy experimental mystery, filmed in glorious ...
(Date:11/27/2014)... "As a nurse I see patients ... urinary incontinence," said an inventor from Whiting, N.J. "I ... accessory to prevent leakage and keep them dry and ... leakage. This prevents stains on pants, skirts and bottoms, ... ensures that the individual has time to get to ...
(Date:11/27/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Thanksgiving meals ... eat a gluten-free diet, an expert says. Many ... potatoes and cranberry sauce -- are gluten-free, but "when ... may need to be considered," Dr. Anca Safta, director ... Wake Forest Baptist Medical Center in North Carolina, said ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Tylenol lawsuits ... were allegedly injured by the medication are continuing to ... litigation is looking ahead to a status conference in ... a Scheduling Order issued earlier this year, a conference ... 16th at 10:00 a.m. Items likely to be discussed ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay, Top-Rated TripAdvisor Resort in the Turks & Caicos Islands, Offers Special Pre-Christmas & January 2015 Promotions! 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 2Health News:Luciana Lagana and Gregory Graham Join the Award-Winning Cast of the Black-and-White Experimental Mystery Feature Film Omadox. 3Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
... shift workers or those with narcolepsy, scientists say , FRIDAY, ... called orexin-A may be key to undoing the negative mental ... , Orexin-A is a peptide (a kind of protein) made ... at the Wake Forest University School of Medicine in Winston-Salem, ...
... free online until March, presents key articles of interest to ... consider the history of leukemia, and how different ... children , describe new research based ... for treatment to target these sub-types more precisely ...
... State,s Highest Honor for Organizational Performance Excellence, ... Council (MQC) announces Oakwood Healthcare, Inc. as a ... Leadership Award is the highest honor for,organizational performance ... a,rigorous review by a team of examiners who ...
... J. Fox,Foundation has committed up to $3.8 million ... treat Parkinson,s disease by reducing expression,of the protein ... Farrer,PhD, of Mayo Clinic Jacksonville (Florida) with collaborators ... Center will work,to optimize a small interfering RNA ...
... Nurse-to-Patient Staffing Ratios, Ability for Nurses to ... Advocate for Urgent Patient Safety Measures, PHOENIX, Jan. 4 ... major legislation to,make Arizona hospitals safer for patients and strengthen ... patient protections., HB 2041, the Arizona Patient Protection Act, ...
... If index finger is shorter than ring finger you might be ... Women whose index finger is shorter than their ring finger are ... In fact, having a shorter index finger may double the risk ... , The ratio of index finger length to ring finger ...
Cached Medicine News:Health News:Protein Nasal Spray Revives Sleep-Deprived Monkeys 2Health News:Michigan Quality Council (MQC) Names Oakwood Healthcare Inc. 2007 State Quality Award Recipient 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 2Health News:Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinson's Disease 3Health News:Arizona Patient Protection Act Introduced 2Health News:Arizona Patient Protection Act Introduced 3Health News:Fingers Point to Risk for Arthritic Knees 2
... matter what cement youre using, the Vortex Vacuum ... mix. Vortex is stirring up traditional vacuum mixers. ... mix every time. The time-saving crank three ... means less effort and less stirring, cutting down ...
The OsteoJect Bone Cement Delivery System now offers leading technology to physicians with the first-ever reusable driver. The OsteoJect allows precise delivery of bone cement under active fluoro whi...
... Davol has worked in partnership with clinicians ... the benefits of autologous blood to patients. ... autotransfusion reaches new levels of simplicity while ... - resulting in new levels of confidence ...
... for rugged use; perfect tool with power ... helps reduce user fatigue. Internally lubricated for ... so that it will not break if ... extending blade life by 50% compared to ...
Medicine Products: